Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
20.96
-0.68 (-3.14%)
At close: Feb 27, 2026, 4:00 PM EST
20.80
-0.16 (-0.76%)
After-hours: Feb 27, 2026, 7:55 PM EST
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.68 billion as of February 27, 2026. Its market cap has decreased by -24.45% in one year.
Market Cap
2.68B
Enterprise Value
2.69B
1-Year Change
-24.45%
Ranking
Category
Stock Price
$20.96
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $2.68B, an increase of 287.69%. That is a compound annual growth rate of 17.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.68B | -15.70% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
| Nov 9, 2017 | 691.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.90B |
| IDEAYA Biosciences | 2.83B |
| Beam Therapeutics | 2.83B |
| Catalyst Pharmaceuticals | 2.82B |
| Viridian Therapeutics | 2.80B |
| Travere Therapeutics | 2.75B |
| Liquidia | 2.70B |
| Wave Life Sciences | 2.62B |